Shopping Cart
×

Olive Capital

Olive Capital

  • San Francisco, California, United States

  • San Francisco, California,

Stage

  • Seed

Type

Description

Olive Capital (OC) is an early-stage investment firm focused on tech and synthetic biology. OC invests in trailblazing founders working in synthetic biology, software, and emergent platforms at the seed stage..

OC builds on the experience of founding partner Olivia Wang, who previously headed up the USoffice of ZhenFund, managing an AUM of $2 billion and a portfolio of 40+ companies.

Mission

Olive Capital (OC) is an early-stage investment firm focused on tech and synthetic biology. OC invests in trailblazing founders working in synthetic biology, software, and emergent platforms at the seed stage. Our vast VC network and strong founder relationships grant us access to competitive investment rounds, often as the sole small fund alongside institutional heavyweights. OC Fund I launched in 2021, and OC Fund II is currently in the pipeline.

Beauty Investments #

  • 1

Primary Sector

  • Tech/Consumer/Beauty

Beauty Exits #

  • 0

Last Beauty Invest

  • approx. $1M,
    Seed Round – Mother Science, 2022

BEAUTY PORTFOLIO

How to Apply?

email info@olivevc.com

Criteria

Olive Capital (OC) is an early-stage investment firm focused on the tech and synthetic biology sectors. Our portfolio includes diverse companies in these spaces, including Pardes (NASDAQ: PRDS), Akasa, Science, Substack, Ender, Orchid Health, and Rewind.

Resources Breakdown Funding Terms
  • $3M to $25M

  • N/A

Education
  • No
Accelerator
  • Type-No
  • Duration-No
Network
  • 14
1:1

IMPERATIVE: CULTURE & VALUES

TBD

TBD

TBD

TBD

TBD

TBD

BEAUTY FUNDER FIT SCORE

Resources

Education

Accelerator

Network

1:1

2.75/10

Inclusivity Investments %
  • 21.43%
Beauty Investments #
  • 1

Beauty Exits #
  • 0
Last Beauty Invest
  • approx. $1M,
    Seed Round – Mother Science, 2022

LEAD DETAILS

Lead Contact

Olivia Wang

Title

Investor

LinkedIn

Twitter Handle

JUMP CONCLUSION

Olive Capital focuses on early-stage tech and healthcare companies, particularly in biotechnology, with a preference for California-based firms, aligning with their San Francisco headquarters. They participate in diverse investments across the US and internationally, such as in Hong Kong, without leading investment rounds, reflecting a collaborative approach. Their portfolio spans software, AI, healthcare, and biotech, indicating a specialized yet broad focus within tech and synthetic biology. Startups in tech and synthetic biology sectors, based in California or major innovation hubs, with innovative approaches to healthcare, biotech, and AI, could attract Olive Capital for future investments.

For a beauty brand to be attractive, you could make a case around back-end biotech and Ai-powered formulations and R&D, even though the Beauty Funder Fit is Avoid

Layer 1